Pittenger & Anderson Inc’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.11M Buy
+52,000
New +$4.42M 0.15% 122
2025
Q1
Sell
-2,415
Closed -$200K 436
2024
Q4
$200K Buy
+2,415
New +$190K 0.01% 221
2023
Q3
Sell
-93
Closed -$5.54K 440
2023
Q2
$5.54K Hold
93
﹤0.01% 391
2023
Q1
$5.27K Hold
93
﹤0.01% 384
2022
Q4
$6.91K Hold
93
﹤0.01% 361
2022
Q3
$6K Buy
93
+18
+24% +$1.08K ﹤0.01% 366
2022
Q2
$4K Buy
75
+2
+3% +$131 ﹤0.01% 388
2022
Q1
$5K Hold
73
﹤0.01% 381
2021
Q4
$5K Hold
73
﹤0.01% 393
2021
Q3
$6K Buy
73
+27
+59% +$2.17K ﹤0.01% 383
2021
Q2
$4K Hold
46
﹤0.01% 366
2021
Q1
$3K Buy
46
+8
+21% +$507 ﹤0.01% 363
2020
Q4
$2K Buy
38
+8
+27% +$460 ﹤0.01% 355
2020
Q3
$1K Buy
+30
New +$1.55K ﹤0.01% 356

Other funds holding GMED

Pittenger & Anderson Inc's GMED Position: Q2 2026 in Review

Pittenger & Anderson Inc opened a new position in Globus Medical (GMED) in Q2 2026: 52,000 shares worth $4.11M. The stake represents 0.15% of the portfolio and ranks #122 among its holdings. This is a return to the name: Pittenger & Anderson Inc previously reported a position in GMED as recently as Q4 2024.

Pittenger & Anderson Inc first reported a position in GMED in Q3 2020 and has held it in 14 quarters since. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Pittenger & Anderson Inc held 52,000 shares of Globus Medical worth $4.11M as of Q2 2026.
  • Globus Medical was a new Pittenger & Anderson Inc position in Q2 2026.
  • Globus Medical made up 0.15% of Pittenger & Anderson Inc's portfolio in Q2 2026, its #122 holding.
  • Pittenger & Anderson Inc first reported a position in Globus Medical in Q3 2020 and has held it in 14 quarters since.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Pittenger & Anderson Inc's 13F filing for Q2 2026, filed 27 Jul 2026.